TNF and rheumatoid arthritis: In 2014, Miao et al. analyzed the association of circulating Th17 and Th1 cells expressing CD161 with disease activity in RA patients with disease duration of about 4 years under treatment with corticosteroids, disease-modifying anti-rheumatic drugs (DMARDs), or TNF inhibitors [46].